Adagio Medical Holdings ADGM
NASDAQ ADGM
$0.64 +0.01 (+0.95%)
At close: Aug 20, 2026 · 10:13 AM UTC

Adagio Medical Holdings (ADGM) Revenue (2023 - 2024)

Adagio Medical Holdings (ADGM) posted Revenue of $132000.0 for Q3 2024, down 48.03% sequentially from $254000.0 in Q2 2024, and up 221.95% YoY from $41000.0 in Q4 2023.

Adagio Medical Holdings (ADGM) Revenue (2023 - 2024) Analysis & Trends

Adagio Medical Holdings has reported Revenue for 2 years, with the latest figure at $132000.0 in Q3 2024.

  • Quarterly Revenue rose 221.95% year-over-year to $132000.0 in Q3 2024, while the trailing twelve-month figure through Dec 2025 was $132000.0 (changed N/A YoY) and the FY2024 annual result came in at $269000.0, down 10.33% from the prior year.
  • Revenue slipped to $132000.0 in Q3 2024 per ADGM's latest filing, from $254000.0 in the prior quarter.
  • Over five years, Revenue peaked at $254000.0 in Q2 2024 and troughed at $26000.0 in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Abbott Laboratories 199.90 Bn 194.30 Bn 7.27 Bn 12.59 Bn
2 Stryker 130.01 Bn 126.54 Bn 4.50 Bn 6.59 Bn
3 Medtronic 120.53 Bn 111.31 Bn 6.41 Bn 9.81 Bn
4 Boston Scientific 74.77 Bn 74.24 Bn 3.85 Bn 5.44 Bn
5 Edwards Lifesciences 52.74 Bn 48.49 Bn 1.35 Bn 1.74 Bn
6 Dexcom 34.74 Bn 32.79 Bn 830.00 Mn 1.31 Bn
7 GE HealthCare Technologies 33.78 Bn 31.67 Bn 2.18 Bn 5.30 Bn
8 Koninklijke Philips 26.43 Bn 23.11 Bn 4.55 Bn 9.61 Bn
9 Steris 23.15 Bn 22.67 Bn 684.20 Mn 1.49 Bn
10 Adagio Medical Holdings 13.99 Mn 13.99 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 132,000.00
Jun 30, 2024 254,000.00
Mar 31, 2024 26,000.00
Dec 31, 2023 78,000.00
Sep 30, 2023 41,000.00